Matches in Wikidata for { <http://www.wikidata.org/entity/Q91473933> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91473933 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q91473933 description "scientific article published on 01 March 2019" @default.
- Q91473933 description "wetenschappelijk artikel" @default.
- Q91473933 description "наукова стаття, опублікована 1 березня 2019" @default.
- Q91473933 name "Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply" @default.
- Q91473933 name "Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply" @default.
- Q91473933 type Item @default.
- Q91473933 label "Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply" @default.
- Q91473933 label "Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply" @default.
- Q91473933 prefLabel "Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply" @default.
- Q91473933 prefLabel "Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply" @default.
- Q91473933 P1433 Q91473933-F426F195-4A09-460C-99E8-D3DA7BCC11FA @default.
- Q91473933 P1476 Q91473933-E3DBC81C-456C-4996-B966-F7E25ACFD68F @default.
- Q91473933 P2093 Q91473933-9BA80831-96FB-40E3-B314-C393B99A84B3 @default.
- Q91473933 P304 Q91473933-5A3E05D3-95B5-4D9A-BE7D-8CBEF8A9F7DB @default.
- Q91473933 P31 Q91473933-437563d2-94c9-4d91-896c-5cfbc280d8a1 @default.
- Q91473933 P31 Q91473933-BE8BD7EA-A863-4974-892F-127CA3590F60 @default.
- Q91473933 P356 Q91473933-DFAEF6C2-1DAF-4A66-8F6F-92A430A0C35A @default.
- Q91473933 P433 Q91473933-08288042-10F3-4629-8DED-782641B573A2 @default.
- Q91473933 P478 Q91473933-BBAE60B6-1F16-49A8-9D59-A377FF6296C5 @default.
- Q91473933 P50 Q91473933-A1AD5A58-10A6-4CDE-AE35-39692F67E114 @default.
- Q91473933 P577 Q91473933-1F9383DD-E91B-47C5-959A-84B216D7229A @default.
- Q91473933 P698 Q91473933-4BD21A47-C8A2-411A-89FC-60AA87C0B18B @default.
- Q91473933 P921 Q91473933-0055FF52-21DD-45CD-9BDF-9E9102F86499 @default.
- Q91473933 P921 Q91473933-AED7FA3D-3448-4B4B-B16E-564ED73D67A9 @default.
- Q91473933 P921 Q91473933-BCCA95D5-A6DA-4D40-8D89-C1DC9131DE38 @default.
- Q91473933 P356 APT.15155 @default.
- Q91473933 P698 30746771 @default.
- Q91473933 P1433 Q4726656 @default.
- Q91473933 P1476 "Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply" @default.
- Q91473933 P2093 "Harry L A Janssen" @default.
- Q91473933 P304 "610-611" @default.
- Q91473933 P31 Q13442814 @default.
- Q91473933 P31 Q871232 @default.
- Q91473933 P356 "10.1111/APT.15155" @default.
- Q91473933 P433 "5" @default.
- Q91473933 P478 "49" @default.
- Q91473933 P50 Q91249490 @default.
- Q91473933 P577 "2019-03-01T00:00:00Z" @default.
- Q91473933 P698 "30746771" @default.
- Q91473933 P921 Q418586 @default.
- Q91473933 P921 Q55779876 @default.
- Q91473933 P921 Q7160835 @default.